Wexford Capital

Sailfish Royalty Corp. is a company focused on acquiring gold and silver royalty and streaming agreements across the Americas. Incorporated in 2014 and headquartered in Road Town, British Virgin Islands, Sailfish holds significant interests in several mining projects. Notably, it owns a 3.5% royalty on revenues from the Tocantinzinho gold project in Brazil as well as a gold stream agreement that provides a 3% net smelter return on the San Albino gold project in Nicaragua. Additionally, the company has a royalty interest of up to 3% on the Spring Valley gold project in Nevada. Through these assets, Sailfish aims to generate yield from the growing demand for precious metals.

Shape Memory Medical Inc, based in Santa Clara, California, is a medical device company focused on developing innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. Founded to commercialize cutting-edge medical devices that utilize Shape Memory Polymer (SMP) materials, the company has introduced the first FDA-cleared device employing this technology within the vascular sector. This advancement allows physicians to enhance patient care through improved treatment options. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Bonterra Resources Inc. is a Canadian gold exploration company focused on the acquisition, exploration, and evaluation of mineral properties primarily in the province of Quebec. Incorporated in 2007 and headquartered in Val-d'Or, the company has established a significant land position of approximately 35,000 hectares within the Urban Barry Camp, situated in the mining-friendly Abitibi Greenstone Belt. Bonterra's key projects include the Gladiator Deposit, the Moroy Deposit, and the Barry Deposit. Notably, it operates the only permitted gold mill in the region, facilitating its exploration and mining activities. The company's operations encompass both mineral exploration and mining site care and maintenance, positioning it as a significant player in the Canadian gold sector.

Viseon, Inc. is a medical device company based in Irvine, California, focused on developing innovative technologies for Minimally Invasive Spine Surgery (MISS). Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has created the Voyant technology, which serves as a single-use disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical procedures by projecting the operative field onto a high-definition flat panel display, accessible both in the operating room and remotely. Viseon has rapidly advanced its product development, building a portfolio of devices aimed at improving clinical outcomes in spine surgery. The company holds 13 patents to protect its intellectual property and has formed a Scientific Advisory Board comprised of leading physicians in the field. Initial human-use studies are scheduled to commence soon, following successful pre-clinical trials.

AZTherapies, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on discovering, developing, and commercializing innovative therapies for neurodegenerative diseases, including Alzheimer's, stroke, ALS, and Parkinson's disease. Established in 2011, the company is advancing a clinical-stage pipeline of small molecule drugs designed to address the underlying mechanisms of these conditions, particularly neuroinflammation and the aggregation of amyloid-beta proteins. Its lead candidate, ALZT-OP1, employs a multi-modal approach to potentially halt or slow the progression of Alzheimer's disease, with the Phase 3 COGNITE trial fully enrolled. In addition to Alzheimer's, AZTherapies is also progressing treatments for cognitive impairment following strokes and other related disorders, aiming to enhance the quality of life for aging populations with limited therapeutic options.

Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.

Viseon, Inc. is a medical device company based in Irvine, California, focused on developing innovative technologies for Minimally Invasive Spine Surgery (MISS). Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has created the Voyant technology, which serves as a single-use disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical procedures by projecting the operative field onto a high-definition flat panel display, accessible both in the operating room and remotely. Viseon has rapidly advanced its product development, building a portfolio of devices aimed at improving clinical outcomes in spine surgery. The company holds 13 patents to protect its intellectual property and has formed a Scientific Advisory Board comprised of leading physicians in the field. Initial human-use studies are scheduled to commence soon, following successful pre-clinical trials.

Shape Memory Medical Inc, based in Santa Clara, California, is a medical device company focused on developing innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. Founded to commercialize cutting-edge medical devices that utilize Shape Memory Polymer (SMP) materials, the company has introduced the first FDA-cleared device employing this technology within the vascular sector. This advancement allows physicians to enhance patient care through improved treatment options. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Rebound Therapeutics Corp. focuses on developing single-use, disposable medical devices aimed at enhancing access, imaging, and illumination during minimally invasive surgical procedures. Established in 2015 and headquartered in Irvine, California, the company has rapidly advanced its product line, offering innovative devices designed to improve procedural and clinical outcomes across various surgical specialties, including neurosurgery, spine and orthopedic surgery, and general abdominal surgery. Rebound has assembled a distinguished Scientific Advisory Board of leading minimally invasive surgery physicians and has filed 14 patents to protect its innovative technologies. The company has also completed several pre-clinical studies, paving the way for initial human-use trials that are set to begin soon. As of September 2019, Rebound Therapeutics operates as a subsidiary of Integra LifeSciences Holdings Corporation.

ElMindA Ltd. focuses on developing diagnostic and treatment tools for brain-related disorders through its innovative Brain Network Activation (BNA) technology. This platform integrates electroencephalography and event-related potential testing with machine learning and advanced algorithms to visualize and assess the brain's neural networks. By capturing electrophysiological patterns related to specific cognitive tasks, ElMindA creates high-resolution, three-dimensional representations of functional neural pathways, which can inform the understanding of various brain functions, including sensory processing, attention, and memory. The technology has applications in conditions such as mild traumatic brain injury, major depressive disorder, Parkinson's disease, and ADHD, aiming to enhance clinical practices in neuroscience. Founded in 2006, ElMindA operates from Herzliya, Israel, with an additional office in Glenview, Illinois.

Vantage Sports, Inc. is a data and video analytics platform that specializes in providing in-depth analysis of sports performance. Founded in 2011 and based in Bellevue, Washington, the company offers a comprehensive data collection platform that tracks athlete and franchise statistics, particularly in the NBA, extending beyond conventional metrics. This platform caters to sports teams, media outlets, and fans, enabling them to gather, analyze, and utilize data effectively. By leveraging advanced data-gathering engines, Vantage Sports aims to deliver an extensive and visionary dataset that enhances performance insights for various stakeholders in the sports industry. The company operates as a subsidiary of Competitive Analytics Consulting LLC.

DIG operates a restaurant chain focused on providing fresh, locally sourced meals. With an emphasis on seasonal ingredients, the restaurants offer organic dishes prepared from scratch using vegetables, whole grains, and naturally-raised meats. The company collaborates closely with trusted farmers and producers to ensure high-quality ingredients. Customers can enjoy healthy, expertly crafted meals at an affordable average price, with the convenience of online ordering and direct table service.

OptiScan Biomedical Corporation specializes in developing advanced glucose monitoring systems for use in intensive care units. The company is known for its OptiScanner 5000, an automated bedside platform that provides precise plasma-based glucose measurements using spectroscopy technology, eliminating the need for calibration. This system enables healthcare providers to monitor and respond to changes in glucose levels for critically ill patients effectively. Founded in 1994 and headquartered in Hayward, California, OptiScan Biomedical faced financial challenges, filing for Chapter 11 bankruptcy in June 2020 and subsequently converting to Chapter 7 bankruptcy in November 2020.

Sophono, Inc. is a medical device manufacturer based in Boulder, Colorado, specializing in implantable magnetic bone conduction hearing devices. Founded in 2009, the company focuses on providing solutions for individuals with conductive hearing loss, mixed hearing loss, and single-sided deafness. Its flagship product, the Alpha 2 MPO, offers an abutment-free design that allows for under-the-skin implantation, enhancing user comfort and convenience. Sophono's devices are designed for patients experiencing severe to profound hearing impairment, and they are distributed through clinics. As of 2015, Sophono operates as a subsidiary of Medtronic plc.

Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Ellipse Technologies is a privately-held medical device company based in California, specializing in the development of innovative implantable remote control technology for spinal and orthopedic applications. The company focuses on creating non-invasively adjustable implants designed to address a wide range of conditions, including spinal deformities and orthopedic trauma. Its flagship products include the MAGEC MAGnetic Expansion Control System, which employs a minimally-invasive method to correct spinal deformities through remote adjustment using an external magnetic field, and the PRECICE System, which utilizes adjustable intramedullary rods or bone plates to manage long-bone abnormalities resulting from fractures. Ellipse is dedicated to advancing treatment options in the fields of spinal and orthopedic medicine.

Reverse Medical is a commercial-stage medical device company dedicated to developing innovative solutions for revascularizing patients suffering from acute ischemic strokes. The company specializes in creating embolic protection systems aimed at treating neurovascular disorders, with a strong emphasis on endovascular management of acute stroke conditions. Through its advanced medical technologies, Reverse Medical seeks to improve patient outcomes and enhance the overall standard of care in the treatment of stroke.

International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries — designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.

Infinia Corporation is a solar energy technology company that specializes in the development of innovative power generation systems. The company's flagship product, the PowerDish, is a proprietary solar power generation device that efficiently converts solar energy into electricity. Infinia also provides micro combined heat and power systems targeted at residential energy consumers, as well as solar and biomass-powered electric generators designed for various applications, including deep space missions and remote power needs. The PowerDish is aimed at energy asset developers, utilities, and commercial companies involved in large-scale solar projects, with a global launch anticipated to have begun in late 2010.

Infinia Corporation is a solar energy technology company that specializes in the development of innovative power generation systems. The company's flagship product, the PowerDish, is a proprietary solar power generation device that efficiently converts solar energy into electricity. Infinia also provides micro combined heat and power systems targeted at residential energy consumers, as well as solar and biomass-powered electric generators designed for various applications, including deep space missions and remote power needs. The PowerDish is aimed at energy asset developers, utilities, and commercial companies involved in large-scale solar projects, with a global launch anticipated to have begun in late 2010.

GlobeImmune, Inc. is a biopharmaceutical company based in Louisville, Colorado, dedicated to developing therapeutic products for cancer and infectious diseases through its proprietary Tarmogen platform. The company’s pipeline includes GS-4774, currently in Phase 2 trials for hepatitis B virus treatment, and various candidates targeting cancer, such as GI-6207 for medullary thyroid cancer, GI-6301 for tumors expressing the brachyury protein, and GI-4000 for resected pancreatic cancer. Additionally, GlobeImmune is advancing several candidates for infectious diseases, including GI-19000 for tuberculosis, GI-2010 for HIV, and GI-18000 for hepatitis D virus, currently in preclinical stages. The Tarmogen platform also includes products designed to address challenges in cancer therapy, such as preventing the emergence of mutated escape variants. The company has established strategic collaborations with Gilead Sciences and Celgene Corporation. Originally founded as Ceres Pharmaceuticals in 1995, GlobeImmune changed its name in 2001 to reflect its focus on innovative immunotherapy solutions.

Interventional Spine, Inc. specializes in the design, development, production, and distribution of implantable devices tailored for spine surgery, addressing the needs of patients, surgeons, and hospitals globally. Founded in 2000 and headquartered in Irvine, California, the company has a strong focus on developing innovative solutions for the treatment of osteoporotic fractures, utilizing its proprietary CLASP® technology that enhances fracture fixation in both normal and osteoporotic bone. Interventional Spine offers a range of products, including the Opticage expandable interbody fusion device and the PERPOS PLS System for facet fixation, along with devices aimed at the podiatric and orthopedic trauma markets. The company has successfully implanted thousands of orthopedic trauma products, significantly improving surgical outcomes through enhanced pullout resistance and precise positioning. Interventional Spine operates as a subsidiary of DePuy Synthes, further expanding its reach in the medical device industry.

Epiphany Biosciences, Inc. is a privately-held company based in San Francisco, California, focused on developing therapeutic products and diagnostic technologies to combat pathogenic viruses. The company specializes in creating antiviral therapeutics aimed at preventing the spread of viruses such as varicella zoster virus, Epstein-Barr virus, and hepatitis C virus. To advance its mission, Epiphany has assembled a team of experts in virology, clinical practice, and drug development, leveraging their extensive experience in the pharmaceutical industry. Through its innovative small molecule therapeutics platform, Epiphany aims to address significant public health challenges associated with viral infections.

ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

Encorp is a provider of network technology and infrastructure management services focused on the distributed energy market. The company specializes in energy automation software and grid-interconnection equipment that facilitate the control of various power resources, including engine-generator sets, microturbines, fuel cells, combined heat and power systems, and energy storage devices. By harnessing its advanced Gold Box technology, Encorp enables federal, institutional, and commercial clients to enhance energy savings, security, and efficiency. Its solutions aim to transform the electric grid into a cleaner, more cost-effective, and resilient system. This integration of diverse energy resources is essential for enterprises requiring high-quality, reliable power at predictable costs, while also contributing to the reduction of carbon emissions.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.